© 2000 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Not Acute but Chronic Hypertriglyceridemia Is Associated With Impaired Endothelium-Dependent Vasodilation
Reversal After Lipid-Lowering Therapy by Atorvastatin
From the Departments of Cardiology (F.H.d.M., A.v.d.L., J.W.J.) and General Internal Medicine (A.W.E.W.-R., A.H.M.S., G.J.B.), Leiden University Medical Center; Leiden, the Netherlands.
Correspondence to F.H. de Man, MD, Department of Cardiology, C5-P, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands. E-mail deman{at}cardio.azl.nl
Abstract—There is controversy regarding the relation between hypertriglyceridemia (HTG) and endothelial function. This study was designed to investigate endothelial function in a patient group with chronic HTG, before and during lipid-lowering therapy by atorvastatin. In addition, the effects of acute HTG on endothelial function were studied in normolipidemic individuals. Eight male patients with chronic HTG were studied before and after 6 weeks of lipid-lowering treatment with 80 mg atorvastatin once daily. Ten age-matched control subjects were studied at baseline and immediately after a high-dose infusion of artificial triglycerides. The endothelium-dependent response to serotonin was attenuated in the HTG group, whereas the response to acetylcholine was comparable to the response in the control group. The response to the endothelium-independent vasodilator nitroprusside was comparable in both groups. In response to atorvastatin therapy, serum triglyceride and cholesterol levels decreased significantly by 43% (paired t test, P=0.017) and 38% (paired t test, P=0.012), respectively. After 6 weeks of treatment, the forearm blood flow response to serotonin improved from 63% to 106% (ANOVA, P<0.001). Induction of acute HTG in the control subjects did not affect the forearm blood flow responses to serotonin and nitroprusside; however, the response to acetylcholine was paradoxically increased. In conclusion, patients with chronic HTG have an impaired endothelium-dependent vasodilation to serotonin that is normalized after 6 weeks of lipid-lowering therapy by atorvastatin.
Key Words: endothelium • hyperlipoproteinemia • triglycerides
This article has been cited by other articles:
 |
|
 |
|
  S. Watanabe, T. Tagawa, K. Yamakawa, M. Shimabukuro, and S. Ueda Inhibition of the Renin-Angiotensin System Prevents Free Fatty Acid-Induced Acute Endothelial Dysfunction in Humans Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2376 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Campese, M. K. Nadim, and M. Epstein Are 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective? J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S11 - S17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Miller, C. D. Tulbert, and D. W. Busija Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R157 - R160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Creager, T. F. Luscher, F. Cosentino, and J. A. Beckman Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I Circulation, September 23, 2003; 108(12): 1527 - 1532. [Full Text] [PDF]
|
|
|
|
|
|
E. R. Mohler III, W. R. Hiatt, M. A. Creager, and for the Study Investigators Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease Circulation, September 23, 2003; 108(12): 1481 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ihlemann, C. Rask-Madsen, A. Perner, H. Dominguez, T. Hermann, L. Kober, and C. Torp-Pedersen Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H875 - H882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Capell, C. A. DeSouza, P. Poirier, M. L. Bell, B. L. Stauffer, K. M. Weil, T. L. Hernandez, and R. H. Eckel Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 307 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I J A M Jonkers, A H M Smelt, M Ledeboer, M E Hollum, I Biemond, F Kuipers, F Stellaard, R Boverhof, A E Meinders, C H B W Lamers, et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil Gut, January 1, 2003; 52(1): 109 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Ferrier, M. H. Muhlmann, J.-P. Baguet, J. D. Cameron, G. L. Jennings, A. M. Dart, and B. A. Kingwell Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension J. Am. Coll. Cardiol., March 20, 2002; 39(6): 1020 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. M. Van Mil, A. Spilt, M. A. Van Buchem, E. L. E. M. Bollen, L. Teppema, R. G. J. Westendorp, and G. J. Blauw Nitric oxide mediates hypoxia-induced cerebral vasodilation in humans J Appl Physiol, March 1, 2002; 92(3): 962 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.J.A.M Jonkers, M.A van de Ree, A.H.M Smelt, F.H.A.F de Man, H Jansen, A.E Meinders, A van der Laarse, and G.J Blauw Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia Cardiovasc Res, February 1, 2002; 53(2): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Malik, V. Melenovsky, D. Wichterle, T. Haas, J. Simek, R. Ceska, and J. Hradec Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial -- FAT) Cardiovasc Res, November 1, 2001; 52(2): 290 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A van de Ree, M. V Huisman, F. H de Man, J. C van der Vijver, A.E. Meinders, and G. J Blauw Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin Cardiovasc Res, November 1, 2001; 52(2): 299 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lundman, M. J. Eriksson, M. Stuhlinger, J. P. Cooke, A. Hamsten, and P. Tornvall Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine J. Am. Coll. Cardiol., July 1, 2001; 38(1): 111 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Nestel, H. Shige, S. Pomeroy, M. Cehun, and J. Chin-Dusting Post-prandial remnant lipids impair arterial compliance J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. N. Chan, R. J. MacAllister, H. M. Colhoun, P. Vallance, and A. D. Hingorani Changes in Endothelium-Dependent Vasodilatation and {{alpha}}-Adrenergic Responses in Resistance Vessels during the Menstrual Cycle in Healthy Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2499 - 2504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Paolisso, D. Manzella, M. R. Tagliamonte, M. Barbieri, R. Marfella, G. Zito, M. Bonafè, D. Giugliano, C. Franceschi, and M. Varricchio The BB-Paraoxonase Genotype Is Associated with Impaired Brachial Reactivity after Acute Hypertriglyceridemia in Healthy Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1078 - 1082. [Abstract] [Full Text]
|
|